DexCom, Inc. (DXCM) 是一家上市公司 屬於 醫療保健 板塊，經營於 Medical - Devices 產業. 公司總部位於 San Diego, CA, 美国. 現任CEO為 Jacob Steven Leach.
DXCM 擁有 IPO日期為 2005-04-14, 10,200 名全職員工, 在 NASDAQ Global Select, 市值為 $24.55B.
DexCom, Inc. is a medical device company headquartered in San Diego, California, specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management. The company's product portfolio includes the DexCom G6 integrated CGM system, DexCom ONE for replacing traditional finger-stick blood glucose testing, DexCom Share for remote monitoring, and the Dexcom Real-Time API that enables third-party developers to integrate CGM data into digital health applications. DexCom markets its solutions directly to endocrinologists, physicians, diabetes educators, and healthcare providers across the United States and internationally, with the next-generation G7 system under development. The company also partners with Verily Life Sciences to develop advanced blood-based and interstitial glucose monitoring products.
